We are a biopharmaceutical company focused on the discovery, development and commercialization of innovative therapies intended to improve outcomes in patients sufferings
We have multiple product candidates in development that we believe are well-advanced and strategically de-risked.
Our pipeline includes innovative compounds targeting progressive non-viral liver diseases. Each product candidate is backed by strong preclinical and clinical data, demonstrating our commitment to rigorous science, patient safety, and therapeutic impact.
© Copyright . All Rights Reserved.